GRANULES INDIA LIMITED
LIVE

Serial Number

87111370

Owner

Granules India Limited

Attorney

Daniel Christopherson

Filing Date

Jul 21, 2016

Add to watchlist:

No watchlists yet
View on USPTO

GRANULES INDIA LIMITED Trademark

Serial Number: 87111370 • Registration: 5239804

GRANULES INDIA LIMITED is a trademark filed by Granules India Limited on July 21, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Granules India Limited (7 trademarks)

2nd Floor, 3rd Block, My Home Hub
Hyderabad, TG 500081 , IN

Entity Type: 99

Trademark Details

Filing Date

July 21, 2016

Registration Date

July 11, 2017

Published for Opposition

April 25, 2017

Goods & Services

Acetaminophen; Analgesics; Anti-inflammatories; Anticoagulants; Antifungal preparations; Antihistamines; Antipyretic analgesics; Cough expectorants; Cough treatment preparations; Expectorants; Ibuprofen for use as an oral analgesic; Muscle relaxants; Pain relief medication; Anti-diabetic pharmaceuticals; Anti-diabetic preparations; Anti-diabetic pharmaceuticals; Chemical preparations for pharmaceutical or medical purposes, namely, for antiretroviral use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-fibrotic use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-fungal use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-hypertensive use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-ulcerative use; Chemical preparations for pharmaceutical or medical purposes, namely, for anti-infective use; Cough expectorants; Cough treatment preparations; Paracetamol; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating hypertension; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Therapeutic pharmaceutical for the treatment of multiple screlosis

Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services

Filing History

TEAS SECTION 8 & 9 RECEIVED
Jul 28, 2026 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jul 11, 2026 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jun 5, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jun 5, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jun 5, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Nov 28, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 11, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 25, 2017 NPUB
PUBLISHED FOR OPPOSITION
Apr 25, 2017 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 5, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 13, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 26, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 26, 2017 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 26, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 1, 2016 GNRN
NON-FINAL ACTION E-MAILED
Nov 1, 2016 GNRT
NON-FINAL ACTION WRITTEN
Nov 1, 2016 CNRT
ASSIGNED TO EXAMINER
Nov 1, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 26, 2016 NWOS
NEW APPLICATION ENTERED
Jul 25, 2016 NWAP